This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dai, J. Articles by Allaire, E. Search for Related Content PubMed PubMed Citation Articles by Dai, J. Articles by Allaire, E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Aortic Aneurysm Related Collections Gene therapy Related Article

(Circulation. 2005;112:1008-1015.)
© 2005 American Heart Association, Inc.

Molecular Cardiology

Overexpression of Transforming Growth Factor-ß1 Stabilizes Already-Formed Aortic Aneurysms

A First Approach to Induction of Functional Healing by Endovascular Gene Therapy

Jianping Dai, MD, PhD; Franck Losy, MD; Anne-Marie Guinault, BSc; Carine Pages, BSc; Ignacio Anegon, PhD; Pascal Desgranges, MD, PhD; Jean-Pierre Becquemin, MD; Eric Allaire, MD, PhD

From CNRS UMR 7054, Centre de Recherches Chirurgicales, Université Paris XII, UFR de Médecine (J.D., F.L., A.-M.G., C.P., P.D., J.-P.B., E.A.) and Service de Chirurgie Vasculaire et Endocrinienne, Assistance Publique des Hôpitaux de Paris (J.D., P.D., J.-P.B., E.A.), Hôpital H. Mondor, Créteil, and INSERM U643, Nantes (I.A.), France.

Correspondence to Eric Allaire, CNRS UMR 7054, Centre de Recherches Chirurgicales, 8 Rue du Général Sarrail, 94010 Créteil, France. E-mail allaire{at}club-internet.fr

Received December 24, 2004; revision received April 8, 2005; accepted April 25, 2005.

Background— The cell response to transforming growth factor-ß1 (TGF-ß1), a multipotent cytokine with healing potential, varies according to tissue context. We have evaluated the ability of TGF-ß1 overexpression by endovascular gene therapy to stabilize abdominal aortic aneurysms (AAAs) already injured by inflammation and proteolysis.

Methods and Results— Active TGF-ß1 overexpression was obtained in already-developed experimental AAAs in rats after endovascular delivery of an adenoviral construct encoding for a mutated form of active simian TGF-ß1 and in an explant model using human atherosclerotic AAA fragments incubated with recombinant active TGF-ß1. Transient exogenous TGF-ß1 overexpression by endovascular gene delivery was followed by induction of endogenous rat TGF-ß1. Overexpression of active TGF-ß1 in experimental AAAs was associated with diameter stabilization, preservation of medial elastin, decreased infiltration of monocyte-macrophages and T lymphocytes, and a decrease in matrix metalloproteinase-2 and -9, which was also observed in the explant model, in both thrombus and wall. In parallel with downregulation of the destructive process, active TGF-ß1 overexpression triggered endoluminal reconstruction, replacing the thrombus by a vascular smooth muscle cell–, collagen-, and elastin-rich intima.

Conclusions— Local TGF-ß1 self-induction after transient exogenous overexpression reprograms dilated aortas altered by inflammation and proteolysis and restores their ability to withstand arterial pressure without further dilation. This first demonstration of stabilization of expanding AAAs by delivery of a single multipotent self-promoting gene supports the view that endovascular gene therapy should be considered for treatment of aneurysms.

---

 

CLINICAL PERSPECTIVE

Related Article:

Gene Therapy to Treat Aortic Aneurysms: Right Goal, Wrong Strategy

Gilbert R. Upchurch, Jr
Circulation 2005 112: 939-940. [Extract] [Full Text]

This article has been cited by other articles:

				G. Ailawadi, C. W. Moehle, H. Pei, S. P. Walton, Z. Yang, I. L. Kron, C. L. Lau, and G. K. Owens Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1392 - 1399. [Abstract] [Full Text] [PDF]

				A. D. Frutkin, G. Otsuka, A. Stempien-Otero, C. Sesti, L. Du, M. Jaffe, H. L. Dichek, C. J. Pennington, D. R. Edwards, M. Nieves-Cintron, et al. TGF-{beta}1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E-Null Mice Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1251 - 1257. [Abstract] [Full Text] [PDF]

				V. L. King, A. Y. Lin, F. Kristo, T. J.T. Anderson, N. Ahluwalia, G. J. Hardy, A. P. Owens III, D. A. Howatt, D. Shen, A. M. Tager, et al. Interferon-{gamma} and the Interferon-Inducible Chemokine CXCL10 Protect Against Aneurysm Formation and Rupture Circulation, January 27, 2009; 119(3): 426 - 435. [Abstract] [Full Text] [PDF]

				J. M. Ruddy, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis Regional heterogeneity within the aorta: Relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1123 - 1130. [Abstract] [Full Text] [PDF]

				J.-F. Deux, J. Dai, C. Riviere, F. Gazeau, P. Meric, B. Gillet, J. Roger, J.-N. Pons, D. Letourneur, F. P. Boudghene, et al. Aortic Aneurysms in a Rat Model: In Vivo MR Imaging of Endovascular Cell Therapy Radiology, December 1, 2007; 246(1): 185 - 192. [Abstract] [Full Text] [PDF]

				M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-{beta} signaling in vascular fibrosis Cardiovasc Res, May 1, 2007; 74(2): 196 - 206. [Abstract] [Full Text] [PDF]

				R. M. Weiss Lasting Effects of Lost Vascular Elasticity Circ. Res., March 16, 2007; 100(5): 604 - 606. [Full Text] [PDF]

				S. P. Tull, S. I. Anderson, S. C. Hughan, S. P. Watson, G. B. Nash, and G. E. Rainger Cellular Pathology of Atherosclerosis: Smooth Muscle Cells Promote Adhesion of Platelets to Cocultured Endothelial Cells Circ. Res., January 6, 2006; 98(1): 98 - 104. [Abstract] [Full Text] [PDF]

				G. R. Upchurch Jr Gene Therapy to Treat Aortic Aneurysms: Right Goal, Wrong Strategy Circulation, August 16, 2005; 112(7): 939 - 940. [Full Text] [PDF]